Values First Advisors Inc. Boosts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Values First Advisors Inc. lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 46.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,671 shares of the exchange traded fund’s stock after purchasing an additional 845 shares during the quarter. Values First Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $238,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Resources Management Corp CT ADV boosted its stake in SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after buying an additional 326 shares during the period. Tyler Stone Wealth Management purchased a new position in SPDR S&P Biotech ETF during the second quarter worth $33,000. EPG Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after buying an additional 278 shares during the period. Compass Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter worth $34,000. Finally, Fortis Capital Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $38,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI traded down $0.02 on Thursday, hitting $94.89. 10,197,612 shares of the company’s stock were exchanged, compared to its average volume of 11,771,370. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The stock has a market capitalization of $7.28 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The business’s 50 day simple moving average is $93.27 and its two-hundred day simple moving average is $82.57.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.